The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
b.r.a.h.m.s | 571 |
holsboermaschmeyer neurochemie | 4 |
bioassays | 4 |
sanko junyaku | 3 |
brahms ag (de) | 2 |
eisai r&d management company | 2 |
sphingo tec | 1 |
ge medical | 1 |
adrenomed | 1 |
sanko junyaku co., | 1 |
b.r.a.h.m.s | 71 |
bioassays | 3 |
b.r.a.h.m.s | 30 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
use of procalcitonin (pct) in risk stratification and prognosis of patients with a prima… 🛈 | 41 | 2007 |
procalcitonin 3-116 | 19 | 1998 |
diagnosis and risk stratification using nt-proet-1 | 19 | 2007 |
diagnosis and risk stratification of infections and chronic diseases of the respiratory … 🛈 | 18 | 2006 |
prognostic biomarkers for the progression of primary chronic kidney disease | 18 | 2008 |
biomarkers for the prediction of incident cancer | 18 | 2010 |
molecular markers for urinary tract infections | 17 | 2010 |
prediction of outcome in patients with chronic obstructive pulmonary disease | 17 | 2012 |
prognosis of adverse events in patients with suspected chronic heart failure | 16 | 2012 |
risk stratification for acute coronary syndrome by means of fragments/partial peptides o… 🛈 | 16 | 2006 |